Mydecine Innovations Group Inc C.MYCO

Alternate Symbol(s): MYCOF

Mydecine Innovations Group Inc. is a Canada-based biotechnology company. The Company is engaged in developing medications and therapies to address mental health disorders, such as nicotine addiction and posttraumatic stress disorder (PTSD). The Company conducts research and development on second generation compounds in Canada with a focus on developing and commercializing psychedelic-inspired regulated medicines. The Company has two lead 3,4-Methylenedioxymethamphetamine (MDMA) candidates. The Company is channeling its MYCO-005, MYCO-006, and MYCO-007 families of patent-pending second-generation MDMA and Psilocybin analogs through Applied Pharmaceutical Innovation (API). It utilizes artificial intelligence (AI) and pharma research infrastructure at the University of Alberta to develop and manufacture new medications to make them accessible to the general public upon Health Canada and Food and Drug Administration (FDA) approval.

CSE:MYCO - Post by User

Mydecine Innovations Group Inc

Bullboard Posts

Comment by SmoothInvstr8on Apr 13, 2019 4:46pm

66 Views

Post# 29623374

RE:What about the 95% of outstanding shares that DON'T trade?

Good idea. A lil rest won’t hurt you. You’re talking about the pumpers and the biggest NF pumper in here. The market cap is way low, 8M yikes, way not good. What is the most important with your beloved NF is the o/s OUTSTANDING SHARES!!! Only 7M, do you understand ? Go sleep, you definitely need it.

Bullboard Posts

NervGen Pharma: Proof that NVG-291 works?